RE: Directors share buy10 Jun 2020 13:53
I did post this when the last director bought but as we are talking about it again today I thought it was worth reporting.
I had a look at Dr Andrew Heath who bought shares today. If you look at his bio below which is very impressive. Interesting he has lead a company before to an acquisition. Obviously no fool and if he is buying shares at £3.05 a pop he must know the value is going to supercharge past this.
Good indication imo.
Dr Andrew Heath was appointed to Oxford Biomedica's Board in January 2010 and became Deputy Chairman and Senior Independent Director in May 2011. Previously he was Chief Executive Officer of Protherics plc where he managed the company’s significant growth and eventual acquisition by BTG for £220 million. Previously, he held senior positions at Astra AB and Astra USA, including Vice President Marketing & Sales, and at Glaxo Sweden as Associate Medical Director. He is currently Chairman of Shield Therapeutics plc, and a non-executive director of Novacyt SA and IHT Partners, LLC. He was previously a director of the UK BioIndustry Association.